<?xml version="1.0" encoding="UTF-8"?>
<p>Influenza vaccination can offer some protection against seasonal influenza infection for the individual, while contributing to reduced risk of ongoing transmission via establishment of herd immunity [
 <xref rid="pcbi.1007096.ref003" ref-type="bibr">3</xref>, 
 <xref rid="pcbi.1007096.ref004" ref-type="bibr">4</xref>]. Influenza vaccines are designed to protect against three or four different influenza viruses; two influenza A viruses (an A(H1N1)pdm09 subtype and A(H3N2) subtype) and either one or two influenza B viruses (covering one or both of the B/Yamagata and B/Victoria lineages). In 2013, 40% of countries worldwide recommended influenza vaccination in their national immunisation programmes, although vaccine uptake varies [
 <xref rid="pcbi.1007096.ref005" ref-type="bibr">5</xref>â€“
 <xref rid="pcbi.1007096.ref007" ref-type="bibr">7</xref>].
</p>
